reference/35298232

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/35298232

Outgoing Links

Predicate	Object
contentType	Journal Article
issn	2162-3619
issueIdentifier	1
pageRange	67-
publicationName	Experimental Hematology & Oncology
startingPage	67
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4dff0655d1f91b995e64cf5e63e31d43 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5c104303e6441e25268d707d160283bc http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f650bc50574756993f897bd5573bf3f7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_41248595e86fdca9a48b447d152df886 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_70abf1ffb7b93a873efff855532f08ab http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_ca072dca00a8fcc8c2389400a1ee7ddd http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_19284ad7d528ea9b4e68b829cc964014 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_9e5036efa644ee6c2eb60a8e654d4eb0 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b08fdcbc66526edae8183c0cf0376233 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_4ea1bdd860d6060bb8b0c1419a8c5c7f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_abb75b1a459266d0475c9b321fab73fa http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_274a87fdd2d7d6aaba9a3774c9e5d285 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_034a6b1cb6fceab8e3efe01b3ce4e850 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e6865aa1eb8e52856a10c96d4055903e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_30f7e8f68bb048ccda7feaa1208f9eff
bibliographicCitation	Cao X, Dai H, Cui Q, Li Z, Shen W, Pan J, Shen H, Ma Q, Li M, Chen S, Chen J, Zhu X, Meng H, Yang L, Wu D, Tang X. CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia. Experimental Hematology & Oncology. 2022 Sep 29;11(1):67. doi: 10.1186/s40164-022-00318-6.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_dea40ff36fed8ea9ac0c78fcfa805028 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f7a269c7da40ca429682d099f729c83d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16e75832cc69a51e801f9adc07c885ce http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_569d407236ac27911ad25bf04db2e838 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a6edd77943d8f9ea66c80c5e70655c0f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ccc1dfe906350704c895d4d0876b786 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_96cd295850345de164fd6cf8f4ae2488 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_00c886525eb18f04b0c3f2bcf7947baa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3e2591d2b52cc66622d03c23b44bc49 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2d77a66e6a44a20f2331107143cf102f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab01ae9bd45a7acdc853e9a0b0641450 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b7666e6c41cbc13889eef9f47a11d5a0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bbe20a03728ee1e095afdf072d1caed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_21f8f6fa89453a6218b1f5221d595e3f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a063901e9a5340ea04bd7d48d58fa9e4
date	2022-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1186/s40164-022-00318-6 https://pubmed.ncbi.nlm.nih.gov/36175988 https://pubmed.ncbi.nlm.nih.gov/PMC9523980
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40664 https://portal.issn.org/resource/ISSN/2162-3619
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ https://scigraph.springernature.com/
title	CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute myeloid leukemia
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_45bd205c63f9c9cfc7d5ba167cb355f0 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4a3d2c0fd0f3365ce05272baa733cf92 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8300 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6700 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a03cbeca561fb1c14c97da4488860cbe http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9731 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_52a517e173e6fa70285ded085be0d86f http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID451668 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10523 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_72346edf1e7eb8a030281f780fefe3fd http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID49846579

Total number of triples: 63.